Tuberculosis News and Research

Latest Tuberculosis News and Research

Switzerland creates new centre for vaccine research

The Institute will develop an immunology, microbiology and vaccine research laboratory platform to encourage cooperation between scientists working in the field of HIV, malaria, tuberculosis, influenza and cancer vaccine development in Switzerland, from fundamental to clinical researchers.

4 Dec 2007

TB appears again in the U.S.

Officials from the Colorado Department of Public Health and the Environment in the U.S. say a Nepalese student at Colorado State University-Pueblo who died of tuberculosis in June, probably infected 17 other people.

26 Nov 2007

Discovery of new signaling molecule could lead to the development of new treatments for cancer

Investigators at St. Jude Children's Research Hospital have discovered a new signaling molecule that prevents immune responses from running amok and damaging the body.

21 Nov 2007

First genome sequence of XDR strain of the bacterium Mycobacterium tuberculosis

An international collaboration led by researchers in the US and South Africa today announced the first genome sequence of an extensively drug resistant (XDR) strain of the bacterium Mycobacterium tuberculosis, one linked to more than 50 deaths in a recent tuberculosis (TB) outbreak in KwaZulu-Natal, South Africa.

21 Nov 2007

Measures that are needed to curb humanity's most fatal diseases

Several of the world's most eminent health scientists and organizations today publish a landmark global consensus on the 20 foremost measures needed to curb humanity's most fatal diseases, their study featured in Nature magazine.

21 Nov 2007

Combining medications often best strategy to battle rheumatoid arthritis

For patients with rheumatoid arthritis, combining one well-known, lower-cost synthetic drug with one of six biologic medications often works best to reduce joint swelling or tenderness, according to a new report by researchers at the RTI International-University of North Carolina at Chapel Hill Evidence-based Practice Center, which is sponsored by the Agency for Healthcare Research and Quality.

19 Nov 2007

Breakthrough innovation for high sensitivity TB and Malaria diagnostics

At this year's 39th World Forum for Medicine in Dusseldorf (MEDICA, November 14-17), Partec, a globally leading developer, manufacturer and provider of dedicated diagnostic solutions in the response to HIV/AIDS, Tuberculosis and Malaria is presenting a breakthrough innovation for high sensitivity TB and Malaria diagnostics in low- and middle-income countries.

15 Nov 2007

BCG vaccine causing illness, death among HIV-positive infants, report says

The BCG vaccine, which aims to prevent tuberculosis among children in developing countries, might be causing illness and death among some HIV-positive infants, researchers said on Friday, the Los Angeles Times reports.

6 Nov 2007

Global Fund, World Bank provide Malawi with $48.5 million to expand HIV/AIDS services, commission says

Malawi's National AIDS Commission in a statement issued Thursday announced that it has received $48.5 million from the Global Fund To Fight AIDS, Tuberculosis and Malaria and the World Bank to expand HIV/AIDS services in the country up to December, Xinhua News Agency reports.

5 Nov 2007

U.N., Google, Cisco Systems launch web site aimed at providing data on Millennium Development Goals

The United Nations, Google and Cisco Systems on Thursday launched a Web site aimed at providing data and information on global efforts to meet the U.N. Millennium Development Goals, the AP/International Herald Tribune reports.

5 Nov 2007

TB vaccine can be a killer for babies with HIV

Experts in South Africa say a vaccine which was meant to protect children in developing countries from tuberculosis (TB)may in fact be killing them.

4 Nov 2007

Tuberculosis breaches borders, but not public health

Immigrants from countries with high rates of tuberculosis who move to countries of low TB incidence do not pose a public health threat to native citizens, according to researchers in Norway, who analyzed the incidence and genetic origins of all known cases of TB in the country between 1993 and 2005.

2 Nov 2007

Infectious diseases experts applaud STAAR Act

With methicillin-resistant Staphylococcus aureus (MRSA) infections, extensively drug-resistant tuberculosis, and other "bad bugs" routinely making headlines, infectious diseases physicians are applauding Sens.

1 Nov 2007

Clinton signs pledge to commit to fight against HIV/AIDS

Sen. Hillary Rodham Clinton (D-N.Y.), who is running for the Democratic presidential nomination, recently signed a pledge to commit to investing $50 billion by 2013 to fight HIV/AIDS domestically and worldwide, the New York Times reports. Clinton also plans to issue a formal policy on the disease, according to the Times (Seelye, "The Caucus," New York Times, 10/26).

30 Oct 2007

New treatment option studied for bladder cancer

A chemotherapy regimen for patients with advanced bladder cancer who aren't eligible for standard treatment is under study at the Medical College of Georgia.

29 Oct 2007

One-third of people with TB in U.S. unaware of HIV status

Nearly one-third of people living with tuberculosis in the U.S. are unaware of their HIV status, according to a study published Friday in CDC's Morbidity and Mortality Weekly Report, Reuters reports (Dunham, Reuters, 10/25).

29 Oct 2007

Promising new tuberculosis drug given special status

Approximately one-third of the world's population is infected with Mycobacterium tuberculosis, the bacterium that causes TB, and an estimated 1.6 million people died of the disease in 2005.

25 Oct 2007

5% of MRSA patients in U.S. died

One of every 20 (or 5 percent) of the roughly 368,600 patients treated in U.S. hospitals in 2005 for Methicillin-resistant staphylococcus aureus, or MRSA, died, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.

25 Oct 2007

Infliximab scheduled treatment has proven to be an effective strategy in IBD patients

Crohn's disease (CD) and ulcerative colitis (UC) are chronic-relapsing diseases, the clinical courses of which are characterized by periods of remission and periods of acute flare up, determining clinical symptoms which have a strong impact on the quality of life for patients.

25 Oct 2007

French clay fights flesh-eating bug

French clay that kills several kinds of disease-causing bacteria is at the forefront of new research into age-old, nearly forgotten, but surprisingly potent cures.

25 Oct 2007